Value in Health Goes Back to the Future to Celebrate Its Past

Published May 20, 2019

20th Anniversary Issue Focuses on “Value” in Healthcare

Lawrenceville, NJ, USA—May 20, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research (HEOR), announced today the publication of a special 20th anniversary issue that reflects on how “value” has been defined, measured, and debated in the journal for the past two decades. To mark the occasion, the Editors commissioned articles that dealt with topics that have been widely discussed in the journal over the past 20 years, but for which there is an exciting future agenda in the field of HEOR.

The papers in this special issue are organized in three distinct categories:

  1. Notions of “Value” in Healthcare. This section includes papers that discuss the clinical, economic, and health-related quality-of-life components, as well as the role of patient-reported outcomes, as one of the central notions of defining and assessing value.
  2. Decision-Analytic Modeling. Perhaps the journal’s most significant contribution to the literature has been in the development of methodological standards in decision-analytic modeling. Papers in this section discuss the role of modern software tools, machine learning, and artificial intelligence to analyze large, real-world data sets to increase efficiency in the provision of healthcare.
  3. HEOR in the Broader Context of HTA and Comparative-Effectiveness Research. Recognizing the methodological and practical challenges of using HEOR in decisions regarding the reimbursement of health technologies, the papers in this section examine the key differences that influence the use of health technology assessment (HTA) and how it is practiced around the world.  

The 20th anniversary issue of Value in Health debuts a bold new look for the publication that aligns with the Society’s new branding. The new journal design reflects a more contemporary look that features a new cover, new page layout, and the use of color to improve overall readability.

Michael F. Drummond, MCom, DPhil (Centre for Health Economics, University of York, York, England, UK) and C. Daniel Mullins, PhD (Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland, USA) have served as Editors-in-Chief of Value in Health since 2011. Under their leadership and editorial direction, the journal has matured into a top-ranked, high-impact journal in the field.

“The science of HEOR has certainly evolved over the past two decades and ISPOR has been a major driver of some of that scientific advancement,” said Drummond. “As the current Editors-in-Chief, we are proud of what Value in Health has achieved over the past 20 years, said Drummond.

“We see our role as maintaining the high standards that the journal has already established and improving on them,” said Mullins. “A key part of this task is to anticipate the changes we are likely to see in the field of HEOR as the environment for healthcare products and services changes in the future. If we can achieve that, Value in Health will continue to deliver “value” to its readers and its authors well into the future.”

###

ABOUT ISPOR

ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

ABOUT VALUE IN HEALTH

Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2017 impact factor score is 5.494. Value in Health is ranked 3rd among 94 journals in healthcare sciences and services, 3rd among 79 journals in health policy and services, and 6th among 353 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: www.ispor.org/valueinhealth | Twitter: www.twitter.com/isporjournals (@ISPORjournals)

Related Stories

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

ISPOR International Panel Calls for Consensus on Medication Adherence Measures

Feb 26, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×